{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:09:35Z","timestamp":1778670575311,"version":"3.51.4"},"reference-count":8,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_almed-2025-0099_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Pulmonary-renal syndrome (PRS) is a serious condition characterized by concurrent alveolar hemorrhage and rapidly progressive glomerulonephritis. One of the potential causes of PRS is the presence of anti-glomerular basement membrane (anti-GBM) antibodies, which may induce Goodpasture syndrome, a rare, albeit life-threatening, condition associated with a high mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_almed-2025-0099_abs_002\">\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report the case of a 31\u00a0year-old male patient with Huntington\u2019s disease who presented with dyspnea, a dry cough, and asthenia. Urgent laboratory tests demonstrated severe anemia, acute kidney failure, and additional laboratory abnormalities consistent with vasculitis. Chest CT scan revealed diffuse alveolar hemorrhage. The autoimmune panel was anti-GBM positive, thereby leading to diagnosis of Goodpasture syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_almed-2025-0099_abs_003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Goodpasture syndrome is a form of pulmonary-renal syndrome that requires prompt diagnosis and intensive immunosuppressive therapy. Patients may follow a severe course and progress into end-stage renal disease. Early detection of anti-GBM antibodies is essential for diagnosis. The clinical laboratory plays a major role in supporting therapeutic decision-making and treatment response monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/almed-2025-0099","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:35:22Z","timestamp":1767987322000},"page":"160-162","source":"Crossref","is-referenced-by-count":0,"title":["Anti-GBM pulmonary-renal syndrome: when the laboratory makes the difference"],"prefix":"10.1515","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9322-2804","authenticated-orcid":false,"given":"Carmen","family":"Fr\u00edas Ruiz","sequence":"first","affiliation":[{"name":"Servicio de An\u00e1lisis Cl\u00ednicos, Hospital Universitario Nuestra Se\u00f1ora de Candelaria , Santa Cruz de Tenerife , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda D.","family":"Mart\u00edn Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Servicio de An\u00e1lisis Cl\u00ednicos, Hospital Universitario Nuestra Se\u00f1ora de Candelaria , Santa Cruz de Tenerife , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"2026051310150648662_j_almed-2025-0099_ref_001","doi-asserted-by":"crossref","unstructured":"Jennette, JC, Falk, RJ, Bacon, PA, Basu, N, Cid, MC, Ferrario, F, et al.. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013;65:1\u201311. https:\/\/doi.org\/10.1002\/art.37715.","DOI":"10.1002\/art.37715"},{"key":"2026051310150648662_j_almed-2025-0099_ref_002","unstructured":"Zycinska, K, Wardyn, KA, Zielonka, TM, Otto, M. The role of ANCA and anti-GBM antibodies in pulmonary-renal syndrome due to Wegener\u2019s granulomatosis. J\u00a0Physiol Pharmacol 2007;58:839\u201346."},{"key":"2026051310150648662_j_almed-2025-0099_ref_003","doi-asserted-by":"crossref","unstructured":"Tang, M, Zhang, J, Xu, X, Pan, Q, Zhao, H. Clinical characteristics and prognosis of pulmonary renal syndrome in West China. Sci Rep 2023;13:1\u201310. https:\/\/doi.org\/10.1038\/s41598-023-27559-7.","DOI":"10.1038\/s41598-023-27559-7"},{"key":"2026051310150648662_j_almed-2025-0099_ref_004","doi-asserted-by":"crossref","unstructured":"Hellmark, T, Segelmark, M. Diagnosis and classification of Goodpasture\u2019s disease (anti-GBM). J\u00a0Autoimmun 2014;48\u201349:108\u201312. https:\/\/doi.org\/10.1016\/j.jaut.2014.01.024.","DOI":"10.1016\/j.jaut.2014.01.024"},{"key":"2026051310150648662_j_almed-2025-0099_ref_005","doi-asserted-by":"crossref","unstructured":"Manabe, S, Banno, M, Nakano, M, Fujii, T, Kakuta, Y, Nitta, K, et al.. A case of PR3\u2013ANCA-positive anti-GBM disease associated with intrarenal arteritis and thrombotic microangiopathy. CEN Case Rep 2017;6:39\u201345. https:\/\/doi.org\/10.1007\/s13730-016-0240-3.","DOI":"10.1007\/s13730-016-0240-3"},{"key":"2026051310150648662_j_almed-2025-0099_ref_006","doi-asserted-by":"crossref","unstructured":"Segelmark, M, Hellmark, T, Wieslander, J. The prognostic significance in Goodpasture\u2019s disease of specificity, titre and affinity of anti-glomerular-basement-membrane antibodies. Nephron Clin Pract 2003;94:59\u201365. https:\/\/doi.org\/10.1159\/000072022.","DOI":"10.1159\/000072022"},{"key":"2026051310150648662_j_almed-2025-0099_ref_007","doi-asserted-by":"crossref","unstructured":"Levy, JB, Neil, MA, Turner, AJ, Rees, F, Pusey, CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001;134:1033\u201342. https:\/\/doi.org\/10.7326\/0003-4819-134-11-200106050-00009.","DOI":"10.7326\/0003-4819-134-11-200106050-00009"},{"key":"2026051310150648662_j_almed-2025-0099_ref_008","doi-asserted-by":"crossref","unstructured":"Smith, C, Dhaliwal, G, Saint, S, Farkash, EA, Garg, P. Double trouble. N\u00a0Engl J Med 2019;381:1854\u201360. Solomon CG, editors. https:\/\/doi.org\/10.1056\/NEJMcps1810654.","DOI":"10.1056\/NEJMcps1810654"}],"container-title":["Advances in Laboratory Medicine \/ Avances en Medicina de Laboratorio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/almed-2025-0099\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/almed-2025-0099\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:16:32Z","timestamp":1778667392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/almed-2025-0099\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":8,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4,28]]},"published-print":{"date-parts":[[2026,5,12]]}},"alternative-id":["10.1515\/almed-2025-0099"],"URL":"https:\/\/doi.org\/10.1515\/almed-2025-0099","relation":{},"ISSN":["2628-491X"],"issn-type":[{"value":"2628-491X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]}}}